C

Cuorips Inc
TSE:4894

Watchlist Manager
Cuorips Inc
TSE:4894
Watchlist
Price: 4 715 JPY -0.53% Market Closed
Market Cap: 37.9B JPY
Have any thoughts about
Cuorips Inc?
Write Note

Cuorips Inc
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cuorips Inc
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
C
Cuorips Inc
TSE:4894
Other
-ÂĄ16.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Other
-ÂĄ3.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Other
-ÂĄ19.3m
CAGR 3-Years
-2 580%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Other
-ÂĄ2m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharma Foods International Co Ltd
TSE:2929
Other
-ÂĄ12m
CAGR 3-Years
-14%
CAGR 5-Years
35%
CAGR 10-Years
N/A
S
StemRIM Inc
TSE:4599
Other
-ÂĄ1k
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cuorips Inc
Glance View

Market Cap
37.8B JPY
Industry
Biotechnology

Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 46 full-time employees. The company went IPO on 2023-06-27. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The firm provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The firm operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.

Intrinsic Value
234.89 JPY
Overvaluation 95%
Intrinsic Value
Price
C

See Also

What is Cuorips Inc's Other?
Other
-16.7m JPY

Based on the financial report for Mar 31, 2024, Cuorips Inc's Other amounts to -16.7m JPY.

Back to Top